SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 to…

Mineralys Therapeutics, Inc. · 144 filed Apr 13, 2026 at 16:18 ET

At the news

NEUTRALIMPACT 3/10

144 filed Apr 13, 2026 at 16:18 ET

David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 to notify intent to sell up to 14,058 shares of common stock, following a series of prior cashless exercises of stock options. This proposed sale is part of an ongoing pattern of insider transactions over the past several months.

  • David Rodman, an officer, filed Form 144 to sell up to 14,058 shares.
  • The shares are from a broker-assisted cashless exercise of employee stock options on April 13, 2026.
  • Rodman has conducted multiple similar transactions between January and April 2026, totaling over 77,000 shares sold.
  • No unusual timing relative to earnings or major catalysts is indicated.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access